[Topiramate monotherapy: broad spectrum therapy with good tolerance].
D019440:Anti-Obesity Agents / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D003072:Cognition Disorders / Q000188:drug therapy*; D004827:Epilepsy / Q000188:drug therapy*; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use; D009765:Obesity / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D000077236:Topiramate
D019440:Anti-Obesity Agents; D000927:Anticonvulsants; D018696:Neuroprotective Agents; D000077236:Topiramate; D005632:Fructose